Clinical Trial Update: Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 neoadjuvant chemotherapy trial evaluating nab-paclitaxel, doxorubicin, and cyclophosphamide in patients with stage II-III breast cancer. The study has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) (paclitaxel nanoparticle albumin-bound)

Snippet

Sponsor: University of Utah | Conditions: Stages II-III Breast Cancer | Phase 1 | Status: TERMINATED